Search hospitals > Maryland > Bethesda
Suburban Hospital
Claim this profileBethesda, Maryland 20814
Global Leader in Breast Cancer
Global Leader in Cancer
Conducts research for Heart Failure
Conducts research for Heart Disease
Conducts research for Stroke
89 reported clinical trials
4 medical researchers
Summary
Suburban Hospital is a medical facility located in Bethesda, Maryland. This center is recognized for care of Breast Cancer, Cancer, Heart Failure, Heart Disease, Stroke and other specialties. Suburban Hospital is involved with conducting 89 clinical trials across 141 conditions. There are 4 research doctors associated with this hospital, such as Curtiland Deville, Jean L. Wright, Daniel Y. Song, and Michael Siegenthaler.Area of expertise
1Breast Cancer
Global LeaderER positive
HER2 negative
PR positive
2Cancer
Global LeaderStage III
Stage IV
HPV negative
Top PIs
Curtiland DevilleSibley Memorial Hospital1 year of reported clinical research
Studies Prostate Cancer
Studies Glioblastoma
6 reported clinical trials
10 drugs studied
Jean L. WrightSibley Memorial Hospital3 years of reported clinical research
Studies Breast Cancer
Studies Sarcoma
6 reported clinical trials
12 drugs studied
Daniel Y. SongSKCCC at Johns Hopkins3 years of reported clinical research
Studies Prostate Cancer
Studies Prostate Adenocarcinoma
3 reported clinical trials
14 drugs studied
Michael SiegenthalerSuburban Hospital4 years of reported clinical research
Studies Stroke
Studies Bleeding
1 reported clinical trial
2 drugs studied
Clinical Trials running at Suburban Hospital
Prostate Cancer
Laryngeal Cancer
Oropharyngeal Carcinoma
Prostate Adenocarcinoma
Cancer
Breast Cancer
Atrial Fibrillation
Squamous Cell Carcinoma
Oral Cavity Carcinoma
Hypopharyngeal Cancer
Apalutamide + Targeted Radiation
for Prostate Cancer
This phase III trial tests two questions by two separate comparisons of therapies. The first question is whether enhanced therapy (apalutamide in combination with abiraterone + prednisone) added to standard of care (prostate radiation therapy and short term androgen deprivation) is more effective compared to standard of care alone in patients with prostate cancer who experience biochemical recurrence (a rise in the blood level of prostate specific antigen \[PSA\] after surgical removal of the prostate cancer). A second question tests treatment in patients with biochemical recurrence who show prostate cancer spreading outside the pelvis (metastasis) by positron emission tomography (PET) imaging. In these patients, the benefit of adding metastasis-directed radiation to enhanced therapy (apalutamide in combination with abiraterone + prednisone) is tested. Diagnostic procedures, such as PET, may help doctors look for cancer that has spread to the pelvis. Androgens are hormones that may cause the growth of prostate cancer cells. Apalutamide may help fight prostate cancer by blocking the use of androgens by the tumor cells. Metastasis-directed targeted radiation therapy uses high energy rays to kill tumor cells and shrink tumors that have spread. This trial may help doctors determine if using PET results to deliver more tailored treatment (i.e., adding apalutamide, with or without targeted radiation therapy, to standard of care treatment) works better than standard of care treatment alone in patients with biochemical recurrence of prostate cancer.
Recruiting2 awards Phase 3
Hormone + Radiation Therapy
for Prostate Cancer
This phase III trial compares less intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in treating patients with high risk prostate cancer and low gene risk score. This trial also compares more intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in patients with high risk prostate cancer and high gene risk score. Apalutamide may help fight prostate cancer by blocking the use of androgen by the tumor cells. Radiation therapy uses high energy rays to kill tumor cells and shrink tumors. Giving a shorter hormone therapy treatment may work the same at controlling prostate cancer compared to the usual 24 month hormone therapy treatment in patients with low gene risk score. Adding apalutamide to the usual treatment may increase the length of time without prostate cancer spreading as compared to the usual treatment in patients with high gene risk score.
Recruiting2 awards Phase 36 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Suburban Hospital?
Suburban Hospital is a medical facility located in Bethesda, Maryland. This center is recognized for care of Breast Cancer, Cancer, Heart Failure, Heart Disease, Stroke and other specialties. Suburban Hospital is involved with conducting 89 clinical trials across 141 conditions. There are 4 research doctors associated with this hospital, such as Curtiland Deville, Jean L. Wright, Daniel Y. Song, and Michael Siegenthaler.